Information for the public
Olaparib (Lynparza) is recommended as a possible treatment for people with ovarian, fallopian tube or peritoneal cancer that has relapsed, if:
If you have cancer as described above, and your doctor thinks that olaparib is the right treatment, you should be able to have the treatment on the NHS.
Olaparib should be available on the NHS within 3 months of the guidance being issued.
If you are already taking olaparib for ovarian, fallopian tube or peritoneal cancer that is not recommended above, you should be able to continue taking it until you and your doctor decide it is the right time to stop.